Synthesis, Antimicrobial and Anticancer Evaluations of Novel Thiazoles Incorporated Diphenyl Sulfone Moiety

References

• G. Berube, “How to Utilize Academic Research Efforts in Cancer Drug Discovery,” Expert Opinion on Drug Discovery 14, no. 4 (2019): 331–4.
   PubMed Web of Science ®Google Scholar
• H. F. Factsheet, https://www.who.int/news-room/fact-sheets/detail/cancer (2018)
   Google Scholar
• R. Laxminarayan and D. L. Heymann, “Challenges of Drug Resistance in the Developing World,” BMJ 344 (2012): e1567.
   PubMed Web of Science ®Google Scholar
• T. Cushnie and A. J. Lamb, “Recent Advances in Understanding the Antibacterial Properties of Flavonoids,” International Journal of Antimicrobial Agents 38, no. 2 (2011): 99–107.
   PubMed Web of Science ®Google Scholar
• E. Fernández-Delgado, F. de la Cruz-Martínez, C. Galán, L. Franco, J. Espino, E. Viñuelas-Zahínos, F. Luna-Giles, and I. Bejarano, “Pt(II) and Pd(II) Complexes with a Thiazoline Derivative Ligand: Synthesis, Structural Characterization, Antiproliferative Activity and Evaluation of Pro-Apoptotic Ability in Tumor Cell Lines HT-29 and U-937,” Journal of Inorganic Biochemistry 202 (2020): 110870.
   PubMed Web of Science ®Google Scholar
• W. Xie, Y. Wu, J. Zhang, Q. Mei, Y. Zhang, N. Zhu, R. Liu, and H. Zhang, “Design, Synthesis and Biological Evaluations of Novel Pyridone-Thiazole Hybrid Molecules as Antitumor Agents,” European Journal of Medicinal Chemistry 145 (2018): 35–40.
   PubMed Web of Science ®Google Scholar
• S. Eryılmaz, E. T. Çelikoğlu, Ö. İdil, E. İnkaya, Z. Kozak, E. Mısır, M. Gül, and S. Wang, “Derivatives of Pyridine and Thiazole Hybrid: Synthesis, DFT, Biological Evaluation via Antimicrobial and DNA Cleavage Activity,” Bioorganic Chemistry 95 (2020): 103476.
   PubMed Web of Science ®Google Scholar
• N. Ahmed, N. K. Konduru, and M. Owais, “Design, Synthesis and Antimicrobial Activities of Novel Ferrocenyl and Organic Chalcone Based Sulfones and Bis-Sulfones,” Arabian Journal of Chemistry 12, no. 8 (2019): 1879–94.
   Web of Science ®Google Scholar
• G. Manfroni, F. Meschini, M. L. Barreca, P. Leyssen, A. Samuele, N. Iraci, S. Sabatini, S. Massari, G. Maga, J. Neyts, et al. “Pyridobenzothiazole Derivatives as New Chemotype Targeting the HCV NS5B Polymerase,” Bioorganic & Medicinal Chemistry 20, no. 2 (2012): 866–76.
   PubMed Web of Science ®Google Scholar
• G. Chen, H. Ren, A. Turpoff, A. Arefolov, R. Wilde, J. Takasugi, A. Khan, N. Almstead, Z. Gu, T. Komatsu, et al. “Discovery of N-(4′-(Indol-2-yl)Phenyl)Sulfonamides as Novel Inhibitors of HCV Replication,” Bioorganic & Medicinal Chemistry Letters 23, no. 13 (2013): 3942–6.
   PubMed Web of Science ®Google Scholar
• H. A. Khamees, Y. H. E. Mohammed, S. Ananda, F. H. Al-Ostoot, Y. Sangappa, S. Alghamdi, S. A. Khanum, and M. Madegowda, “Effect of o-Difluoro and p-Methyl Substituents on the Structure, Optical Properties and Anti-Inflammatory Activity of Phenoxy Thiazole Acetamide Derivatives: Theoretical and Experimental Studies,” Journal of Molecular Structure 1199 (2020): 127024.
   Web of Science ®Google Scholar
• L. Navarro, G. Rosell, S. Sanchez, N. Boixareu, K. Pors, R. Pouplana, J. M. Campanera, and M. D. Pujol, “Synthesis and Biological Properties of Aryl Methyl Sulfones,” Bioorganic & Medicinal Chemistry 26, no. 14 (2018): 4113–26.
   PubMed Web of Science ®Google Scholar
• M. M. Alsharekh, I. I. Althagafi, M. R. Shaaban, and T. A. Farghaly, “Microwave-Assisted and Thermal Synthesis of Nanosized Thiazolyl-Phenothiazine Derivatives and Their Biological Activities,” Research on Chemical Intermediates 45, no. 2 (2019): 127–54.
   Web of Science ®Google Scholar
• I. I. Althagafi, A. S. Abouzied, T. A. Farghaly, N. T. Al‐Qurashi, M. Y. Alfaifi, M. R. Shaaban, and M. R. Abdel Aziz, “Novel Nano-Sized Bis-Indoline Derivatives as Antitumor Agents,” Journal of Heterocyclic Chemistry 56, no. 2 (2019): 391–9.
   Web of Science ®Google Scholar
• H. K. Mahmoud, T. A. Farghaly, H. G. Abdulwahab, N. T. Al-Qurashi, and M. R. Shaaban, “Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity,” European Journal of Medicinal Chemistry208 (2020): 112752.
   PubMed Web of Science ®Google Scholar
• R. S. Jasass, F. Alshehrei, and T. A. Farghaly, “Microwave‐Assisted Synthesis of Antimicrobial Agents Containing Carbazole and Thiazole Moieties,” Journal of Heterocyclic Chemistry 9 (2018): 2099–106.
   Google Scholar
• M. M. Amin, M. R. Shaaban, N. T. Al‐Qurashi, H. K. Mahmoud, and T. A. Farghaly, “Indomethacin Analogs: Synthesis, Anti-Inflammatory and Analgesic Activities of Indoline Derivatives,” Mini-Reviews in Medicinal Chemistry 18, no. 16 (2018): 1409–21.
   PubMed Web of Science ®Google Scholar
• S. M. Gomha, F. El-Hag, A. El. Defrawy, and T. A. Farghaly, “Synthesis and Quantum Chemical Studies on the Tautomeric Structures of New Thiazole and Thiadiazine Derivatives,” Current Organic Synthesis 13 (2016): 907–16.
   Web of Science ®Google Scholar
• M. Gharbavi, H. K. Manjili, J. Amani, A. Sharafi, and H. Danafar, “In Vivo and In Vitro Biocompatibility Study of Novel Microemulsion Hybridized with Bovine Serum Albumin as Nanocarrier for Drug Delivery,” Heliyon 5, no. 6 (2019): e01858.
   PubMed Web of Science ®Google Scholar
• Y. Zhao, A. Sanchez, S. Ananda, X. Nie, D. Liu, X. Hou, J. Fabrycki, A. Phadke, M. Deshpande, M. Huang, et al. “A Highly Sensitive and Reproducible HCV RNA Hybridization Method Valuable for Antiviral Drug Discovery,” Journal of Virological Methods 151, no. 1 (2008): 154–7.
   PubMed Web of Science ®Google Scholar
• A. M. Alsaedi, T. A. Farghaly, and M. R. Shaaban, “Synthesis and Antimicrobial Evaluation of Novel Pyrazolopyrimidines Incorporated with Mono- and Diphenylsulfonyl Groups,” Molecules 24 (2019): 4009.
   Web of Science ®Google Scholar
• S. A. Al-Hussain, T. A. Farghaly, M. E. A. Zaki, H. G. Abdulwahab, N. T. Al-Qurashi, and Zb A. Muhammad, “Discovery of Novel Indolyl-1,2,4-Triazole Hybrids as Potent Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitors with Potential Anti-Renal Cancer Activity,” Bioorganic Chemistry 105 (2020): 104330.
   PubMed Web of Science ®Google Scholar
• Z. A. Muhammad, M. A. Radwan, T. A. Farghaly, H. M. Gaber, and M. M. Elaasser, “Synthesis and antitumor activity of novel [1,2,4,5]-tetrazepino[6,7-b]indole derivatives: Marine natural product Hyrtioreticuline C and D analogues,” Mini-reviews in Medicinal Chemistry 19 (2019): 79–86.
   PubMed Web of Science ®Google Scholar
• G. S. Masaret and T. A. Farghaly, “Synthesis of 8,10-disubstituted-triazoloperimidines from (E)-3-(dimethylamino)-1-(8-phenyl-8H-[1,2,4]triazolo[4,3-a]perimidin-10-yl)prop-2-en-1-one and their antimicrobial activity,” Current Organic Synthesis 15 (2018): 126–36.
   Web of Science ®Google Scholar
• Z. A. Muhammad, G. S. Masaret, M. M. Amin, M. A. Abdallah, and T. A. Farghaly, “Anti-inflammatory, analgesic and anti-ulcerogenic activities of novel bis-thiadiazoles, bis-thiazoles and bis-formazanes,” Medicinal Chemistry 13 (2017): 226–38.
   PubMed Web of Science ®Google Scholar
• T. A. Farghaly, A. M. Abo Alnaja, H. A. El-Ghamry, and M. R. Shaaban, “Synthesis and DNA Binding of Novel Bioactive Thiazole Derivatives Pendent to N-Phenylmorpholine Moiety,” Bioorganic Chemistry 102 (2020): 104103.
   PubMed Web of Science ®Google Scholar
• N. Eweiss and A. Osman, “Synthesis of heterocycles. Part II. New routes to acetylthiadiazolines and alkylazothiazoles,” Journal of Heterocyclic Chemistry 8 (1980): 1713–17.
   Google Scholar
• A. S. Shawali and H. A. Albar, “Kinetics and Mechanism of Dehydrochlorination of N-Aryl-C-Ethoxycarbonylformohydrazidoyl Chlorides,” Canadian Journal of Chemistry 64, no. 5 (1986): 871–5.
   Web of Science ®Google Scholar
• M. A. Pfaller, L. Burmeister, M. Bartlett, and M. Rinaldi, “Multicenter Evaluation of Four Methods of Yeast Inoculum Preparation,” Journal of Clinical Microbiology 26, no. 8 (1988): 1437–41.
   PubMed Web of Science ®Google Scholar
• J. Vesely, L. Havlicek, M. Strnad, J. J. Blow, A. Donella-Deana, L. Pinna, D. S. Letham, J.-Y. Kato, L. Detivaud, S. Leclerc, et al. “Inhibition of Cyclin-Dependent Kinases by Purine Analogues,” European Journal of Biochemistry 224, no. 2 (1994): 771–86.
   PubMedGoogle Scholar
• A. S. Shawali, M. M. Zayed, T. A. Farghaly, M. A. Abdallah, and G. S. Masaret, “Synthesis and Biological Activity of New 1H-Pyrazolo[3,4-b]Quinoxalines (Flavazoles),” Journal of Heterocyclic Chemistry 42, no. 2 (2005): 185–9.
   Web of Science ®Google Scholar
• A. S. Shawali, M. H. Abdelkader, and F. M. Eltalbawy, “Synthesis and Tautomeric Structure of Novel 3,7-Bis(Arylazo)-2,6-Diphenyl-1H-Imidazo-[1,2-b]Pyrazoles in Ground and Excited States,” Tetrahedron 58, no. 14 (2002): 2875–80.
   Web of Science ®Google Scholar
• T. A. Farghaly, A. S. Shawali, M. A. Abdallah, G. S. Masaret, and Z. A. “Synthesis and Single-Crystal X-Ray Diffraction Analysis of New Heterocyclic Coloured Materials. 3-Arylazo-8H-Imidazo[1,2-b] Pyrazolo[4,3-d]Pyridazines,” Tetrahedron 66, no. 14 (2010): 2700–4.
   Web of Science ®Google Scholar
• A. S. Shawali and T. A. Farghaly, “Synthesis and Tautomeric Structure of 2-[N-Aryl-2-Oxo-2-Arylethanehydrazonoyl]-6-Methyl-4(3H)-Pyrimidinones,” Tetrahedron 60, no. 13 (2004): 3051–7.
   Web of Science ®Google Scholar
• A. S. Shawali, S. M. Sherif, T. A. Farghaly, M. Shehata, and M. A. Darwish, “Synthesis and tautomeric structure of the azo-coupling products of 2-methyl-7-phenylpyrimido[1,2-b][1,2,4]triazepine-4,9(3H,5H)-dione,” Journal of Chemical Research 1 (2007): 44–7.
   Google Scholar
• T. A. Farghaly and M. A. Abdallah, “Synthesis, azo-hydrazone tautomerism and antitumor screening of N-(3-ethoxycarbonyl-4,5,6,7-tetrahydro-benzo[b]thien-2-yl)-2-arylhydrazono-3-oxobutanamide derivatives,” Arkivoc 17 (2008): 295–305.
   Google Scholar